Euronext NV/ NL0006294274 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
38.820EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 9.85 bill.EUR | 2.70% | 19.01 |
GlobeNewswire
06-10
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primar...
GlobeNewswire
05-29
AB Science provides an update on the application for conditional marketing authorisation of masitini...
GlobeNewswire
05-22
VEON Receives Nasdaq Notice on Delayed Filing, Confirms Ongoing Effort to Address Auditor Appointmen...
GlobeNewswire
05-03
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the c...
GlobeNewswire
04-29
Mithra updates on offers received in the context of its monetization process and on its Annual Repor...
GlobeNewswire
04-25
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
GlobeNewswire
03-29
AERKOMM and Nasdaq-Listed IX Acquisition Corp. Announce Merger Agreement and US $35 Million Private ...
GlobeNewswire
03-25
ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France
GlobeNewswire
03-21
ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookb...
GlobeNewswire
03-20
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Publi...
GlobeNewswire
03-20
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Publi...
GlobeNewswire
03-06
AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have ini...